Streptokinase biosimilar - Sedico

Drug Profile

Streptokinase biosimilar - Sedico

Alternative Names: Sedonase

Latest Information Update: 03 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sedico
  • Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Fibrinolytic agents; Plasmin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Central retinal vein occlusion; Deep vein thrombosis; Myocardial infarction; Peripheral arterial occlusive disorders; Pulmonary embolism

Most Recent Events

  • 03 Mar 2014 Launched prior to March 2013 for Deep vein thrombosis in Egypt (IV)
  • 03 Mar 2014 Launched prior to March 2013 for Pulmonary embolism in Egypt (IV)
  • 03 Mar 2014 Launched prior to March 2013 for Central retinal vein occlusion in Egypt (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top